The One IRS Rule Keeping Cannabis Stocks Down Despite Record Cash Flow

Core Insights - The article discusses how IRS Section 280E tax liabilities are hindering the growth of cannabis stocks despite strong cash flow and revenue generation in the sector [1] Group 1: Financial Performance of Cannabis Companies - Trulieve (TCNNF) reported $228.6 million in free cash flow for 2025 on $1.18 billion in revenue, but faces $668 million in uncertain 280E tax liabilities [1] - Green Thumb Industries (GTBIF) CEO Ben Kovler indicated that the stock price reflects federal actions regarding cannabis rescheduling [1] - Curaleaf (CURLF) and Verano (VRNOF) are currently managing debt refinancing and price compression while awaiting relief from 280E [1] Group 2: Market Sentiment and Speculation - Retail options traders are heavily betting on the rescheduling of cannabis from Schedule I to Schedule III, which would eliminate Section 280E tax restrictions [1] - The AdvisorShares Pure US Cannabis ETF (MSOS) has a low put-call ratio of below 0.01, indicating bullish sentiment among traders despite an 18% decline year-to-date [1] - Prediction market traders estimate a 30.5% chance of rescheduling by June 30, with odds improving to roughly even by year-end [1] Group 3: Implications of Rescheduling - Rescheduling cannabis to Schedule III would remove Section 280E, allowing cannabis companies to deduct ordinary business expenses, significantly improving their financial profiles [1] - Trulieve's CEO Kim Rivers noted that the company is poised for growth in 2026, despite a 26% decline in stock value year-to-date, highlighting the disconnect between operational performance and federal policy [1] - Analysts believe that relief from 280E would substantially alter the financial landscape for all operators in the cannabis sector [1]